Tart Cherry for Joint Pain and Inflammation

Tart cherry — specifically Montmorency tart cherry — has carved out a well-earned niche in sports nutrition and joint health research. Unlike many fruit extracts that are tested primarily in cell culture studies, tart cherry has multiple randomized controlled trials in humans showing reductions in muscle soreness, markers of inflammation, and joint pain. The evidence for gout recurrence reduction and knee osteoarthritis pain is particularly interesting.

This article explains what the research actually shows, which forms work, and how to use tart cherry effectively.

What Makes Tart Cherry Different

The active compounds in tart cherry responsible for its anti-inflammatory effects are primarily anthocyanins — the same class of polyphenols that give blueberries and red cabbage their color. Tart cherries, particularly Montmorency cherries, have an exceptionally high anthocyanin concentration compared to most other fruits.

These anthocyanins inhibit COX-1 and COX-2 enzymes — the same enzymes targeted by NSAIDs like ibuprofen and aspirin. They also reduce levels of C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), key markers of systemic inflammation.

Additional compounds in tart cherry include quercetin, chlorogenic acid, and melatonin (which contributes to tart cherry's well-documented effects on sleep quality — a separate but relevant benefit for people dealing with chronic pain).

Evidence for Joint Pain: Knee Osteoarthritis

A 2013 randomized controlled trial published in Osteoarthritis and Cartilage enrolled 58 patients with knee OA and assigned them to either 480ml of tart cherry juice daily (equivalent to about 100–120 cherries worth of anthocyanins) or a placebo drink for 6 weeks. The tart cherry group showed statistically significant improvements in WOMAC pain scores and significant reductions in serum CRP compared to placebo.

The effect sizes were modest but clinically meaningful — roughly comparable to what has been observed with low-to-moderate dose NSAIDs in similar populations, without the gastrointestinal side effects.

A follow-up analysis from the same research group found that the CRP reductions correlated with the magnitude of pain improvements, suggesting the anti-inflammatory mechanism was driving the benefit rather than a non-specific placebo effect.

Evidence for Gout

Gout is caused by the deposition of uric acid crystals in joints, and flares are driven by both elevated serum uric acid and acute inflammatory responses to those crystals. Tart cherry addresses both mechanisms: it lowers uric acid levels modestly and suppresses the inflammatory response.

A prospective study of 633 gout patients (published in Arthritis & Rheumatism, 2012) found that consuming tart cherry over a 2-day period was associated with a 35% reduced risk of gout attack recurrence compared to no intake. When combined with allopurinol (a standard gout medication), the risk reduction rose to approximately 75% compared to neither intervention.

This is not a randomized trial, so causality cannot be definitively established, but the effect size is large enough to be clinically interesting, and the mechanistic basis (uric acid reduction + COX inhibition) is plausible.

Tart cherry is not a substitute for allopurinol or febuxostat in patients with chronic gout, but it may serve as a useful adjunct, particularly for patients trying to reduce flare frequency.

Evidence for Exercise-Induced Muscle Damage

This is where tart cherry's evidence base is most extensive. Multiple RCTs in athletes — marathon runners, cyclists, and resistance training participants — have shown that tart cherry supplementation reduces:

Delayed onset muscle soreness (DOMS) scores
Markers of oxidative stress (e.g., TBARS, protein carbonyls)
Strength loss following eccentric exercise

A 2010 study in the Scandinavian Journal of Medicine & Science in Sports found that marathon runners consuming tart cherry juice for 5 days before and 48 hours after a marathon reported significantly lower pain scores and recovered muscle function more quickly than placebo.

For athletes managing both performance recovery and chronic joint inflammation, tart cherry is one of the more versatile options available.

Forms and Dosing

Tart cherry juice (unsweetened): Most trials use 240–480ml per day of Montmorency tart cherry juice. This is effective but high in sugar and calories — a relevant consideration for people watching carbohydrate intake.

Tart cherry concentrate: This is more practical. Look for concentrated Montmorency tart cherry standardized to a specific anthocyanin content. A common dose is 480mg of concentrate (equivalent to approximately 480ml of juice) taken once or twice daily. Concentrates allow you to get the anthocyanin dose without the sugar load of juice.

Tart cherry capsules/powder: These vary widely in quality and anthocyanin content. Look for products that specify the Montmorency variety and, ideally, state the total anthocyanin content per serving (ideally 40–80mg anthocyanins per dose).

Timing: For OA and gout management, daily consistent use is most important — this is not an acute intervention. For sports recovery, many protocols front-load before and continue through the event period.

Note on sweet vs. tart cherry: Sweet cherries (Bing, Rainier) have much lower anthocyanin concentrations than Montmorency tart cherries. The research specifically uses Montmorency. Don't assume sweet cherry products are equivalent.

Evidence Quality Assessment

The evidence for tart cherry is moderate overall:

Multiple small-to-medium RCTs in sports recovery with consistent results
One meaningful RCT in knee OA with validated outcome measures
Observational data for gout (not RCT-level evidence)
No large-scale, long-duration trials

The evidence is stronger than most fruit extracts but not as robust as pharmaceutical interventions. The risk profile is excellent — tart cherry is a food, not a drug — which lowers the bar for reasonable use.

Safety and Interactions

Tart cherry is very safe for the vast majority of people. Relevant considerations:

Sugar content: If using the juice form, be aware of the carbohydrate load (especially for people with diabetes or insulin resistance — use concentrate or capsules instead).
Anticoagulants: Anthocyanins have mild antiplatelet effects. The clinical significance is low, but people on warfarin should monitor INR more closely when adding tart cherry.
Kidney stones: High oxalate content in cherries may be relevant for people with a history of calcium oxalate stones — though the amounts in typical supplemental doses are modest.
Drug interactions: No major interactions are established, but as with any polyphenol-rich supplement, there is theoretical potential for interaction with drugs metabolized by CYP enzymes.

Tart cherry is not associated with serious adverse events in trials to date.

How to Stack Tart Cherry

Tart cherry works well as part of a joint health stack alongside:

Boswellia — complementary anti-inflammatory mechanism via 5-LOX inhibition
Glucosamine/chondroitin — structural cartilage support
Omega-3 fatty acids (EPA/DHA) — systemic inflammation reduction
Collagen peptides (with vitamin C) — for tendon and cartilage matrix support

For gout specifically, it pairs logically with celery seed extract (another uric acid reducer) and can complement allopurinol, though you should discuss any additions to a gout management plan with your doctor.

Who Should Consider Tart Cherry

Tart cherry is a reasonable option for:

People with knee osteoarthritis looking for a food-derived anti-inflammatory
Individuals with gout trying to reduce flare frequency (as an adjunct to standard care)
Athletes managing post-exercise soreness and chronic joint inflammation
Anyone looking for a natural anti-inflammatory with a favorable safety profile

It is not appropriate as a sole treatment for severe arthritis, active gout flares, or any inflammatory condition requiring medical management.

The Bottom Line

Tart cherry — specifically Montmorency variety — has more credible human trial evidence behind it than most fruit extracts. Its anthocyanin content drives COX inhibition, CRP reduction, and modest uric acid lowering, translating to real-world benefits for knee OA pain and gout recurrence. Concentrate forms at around 480mg/day avoid the sugar burden of juice and are more practical for daily use. It is not a replacement for medications but is one of the better-evidenced natural adjuncts for joint inflammation and uric acid management.

Want to see how tart cherry fits into a complete joint health protocol? Use Optimize free to build a personalized supplement stack based on your health goals.